A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine

Clinical trial NCT00542893 · COMPLETED

Trial details

NCT number: NCT00542893
Sponsor: Genta Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Melanoma

Start date: 2006-04-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.